These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 26392108

  • 1. Overexpression and biological function of TMEM48 in non-small cell lung carcinoma.
    Qiao W, Han Y, Jin W, Tian M, Chen P, Min J, Hu H, Xu B, Zhu W, Xiong L, Lin Q.
    Tumour Biol; 2016 Feb; 37(2):2575-86. PubMed ID: 26392108
    [Abstract] [Full Text] [Related]

  • 2. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
    Han Y, Tian H, Chen P, Lin Q.
    Oncotarget; 2017 Apr 04; 8(14):22730-22740. PubMed ID: 28186994
    [Abstract] [Full Text] [Related]

  • 3. miRNA-mediated apoptosis activation through TMEM 48 inhibition in A549 cell line.
    Akkafa F, Koyuncu İ, Temiz E, Dagli H, Dïlmec F, Akbas H.
    Biochem Biophys Res Commun; 2018 Sep 03; 503(1):323-329. PubMed ID: 29906465
    [Abstract] [Full Text] [Related]

  • 4. Proliferating cell nuclear antigen promotes cell proliferation and tumorigenesis by up-regulating STAT3 in non-small cell lung cancer.
    Wang L, Kong W, Liu B, Zhang X.
    Biomed Pharmacother; 2018 Aug 03; 104():595-602. PubMed ID: 29803172
    [Abstract] [Full Text] [Related]

  • 5. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D, Wang J, Zhang C, Shan B, Deng X, Li B, Zhou Y, Chen W, Hong J, Gao Y, Chen Z, Duan C.
    Mol Cancer; 2015 Apr 01; 14():73. PubMed ID: 25889562
    [Abstract] [Full Text] [Related]

  • 6. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
    Guo D, Wang Y, Ren K, Han X.
    Exp Cell Res; 2018 Jan 01; 362(1):172-179. PubMed ID: 29133127
    [Abstract] [Full Text] [Related]

  • 7. COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance.
    Shen L, Yang M, Lin Q, Zhang Z, Zhu B, Miao C.
    Oncol Rep; 2016 Aug 01; 36(2):877-85. PubMed ID: 27373316
    [Abstract] [Full Text] [Related]

  • 8. βKlotho is identified as a target for theranostics in non-small cell lung cancer.
    Li F, Li X, Li Z, Ji W, Lu S, Xia W.
    Theranostics; 2019 Aug 01; 9(25):7474-7489. PubMed ID: 31695781
    [Abstract] [Full Text] [Related]

  • 9. Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.
    Wu Z, Jiao M, Shu C, Zhang S, Wang J, Pu J, Zhu J, Zeng Y, Zhu Y, Liu Z.
    Cell Commun Signal; 2024 Jun 06; 22(1):313. PubMed ID: 38844957
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Aldolase A promotes proliferation and G1/S transition via the EGFR/MAPK pathway in non-small cell lung cancer.
    Fu H, Gao H, Qi X, Zhao L, Wu D, Bai Y, Li H, Liu X, Hu J, Shao S.
    Cancer Commun (Lond); 2018 May 08; 38(1):18. PubMed ID: 29764507
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Overexpression of PKMYT1 indicates the poor prognosis and enhances proliferation and tumorigenesis in non-small cell lung cancer via activation of Notch signal pathway.
    Sun QS, Luo M, Zhao HM, Sun H.
    Eur Rev Med Pharmacol Sci; 2019 May 08; 23(10):4210-4219. PubMed ID: 31173292
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Low Expression LncRNA TUBA4B is a Poor Predictor of Prognosis and Regulates Cell Proliferation in Non-Small Cell Lung Cancer.
    Chen J, Hu L, Wang J, Zhang F, Chen J, Xu G, Wang Y, Pan Q.
    Pathol Oncol Res; 2017 Apr 08; 23(2):265-270. PubMed ID: 27411923
    [Abstract] [Full Text] [Related]

  • 19. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
    Li Z, Zhu W, Xiong L, Yu X, Chen X, Lin Q.
    Oncotarget; 2016 Sep 20; 7(38):61366-61377. PubMed ID: 27542260
    [Abstract] [Full Text] [Related]

  • 20. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C, Dong X, Lu H, Tong F, Chen L, Zhang R, Dong J, Hu Y, Wu G, Dong X.
    J Exp Clin Cancer Res; 2019 Feb 21; 38(1):95. PubMed ID: 30791942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.